The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs)
| 000 | 00000cam u2200205Ia 4500 | |
| 001 | 000000717483 | |
| 005 | 20240802144703 | |
| 008 | 010307s2000 sz b i000 0 eng d | |
| 010 | ▼a ?01375459 | |
| 020 | ▼a 9241208953 | |
| 040 | ▼a DJB ▼c DJB ▼d AGL ▼d COU ▼d DLC ▼d 211009 | |
| 049 | 1 | ▼l 131010877 ▼f 의학 |
| 070 | 0 | ▼a 449.9 ▼b W892T no. 895 |
| 072 | 0 | ▼a X380 |
| 090 | ▼a 610.62 ▼b W927 ▼c 895 | |
| 110 | 2 | ▼a WHO Expert Committee on the Use of Essential Drugs. |
| 245 | 1 4 | ▼a The use of essential drugs : ▼b ninth report of the WHO Expert Committee (including the revised Model list of essential drugs). |
| 246 | 3 0 | ▼a Model list of essential drugs |
| 260 | ▼a Geneva : ▼b World Health Organization, ▼c 2000. | |
| 300 | ▼a v, 61 p. ; ▼c 24 cm. | |
| 490 | 1 | ▼a WHO technical report series ; ▼v 895 |
| 500 | ▼a "The WHO Expert Committee on the Use of Essential Drugs met in Geneva from 15 to 19 December 1999"--P. 1. | |
| 504 | ▼a Includes bibliographical references (p. 57-61). | |
| 650 | 0 | ▼a Drugs ▼x Prescribing ▼x Congresses. |
| 650 | 0 | ▼a Drug utilization ▼x Congresses. |
| 650 | 2 | ▼a Drug Utilization ▼v Congresses. |
| 650 | 2 | ▼a Drugs, Essential ▼x standards ▼v Congresses. |
| 650 | 2 | ▼a Drugs, Essential ▼x administration & dosage ▼v Congresses. |
| 710 | 2 | ▼a WHO ▼0 AUTH(211009)64026. |
| 710 | 2 | ▼a World Health Organization. |
| 830 | 0 | ▼a Technical report series (World Health Organization) ; ▼v 895. |
소장정보
| No. | 소장처 | 청구기호 | 등록번호 | 도서상태 | 반납예정일 | 예약 | 서비스 |
|---|---|---|---|---|---|---|---|
| No. 1 | 소장처 의학도서관/보존서고4/ | 청구기호 610.62 W927 895 | 등록번호 131010877 | 도서상태 대출가능 | 반납예정일 | 예약 | 서비스 |
컨텐츠정보
목차
CONTENTS 1. Introduction = 1 2. The concept of essential drugs = 1 3. The WHO Model List of Essential Drugs = 2 4. Criteria for the selection of essential drugs = 4 5. Guidelines for the selection of pharmaceutical dosage forms = 6 6. Quality assurance = 6 7. Pharmacovigilance = 7 8. Drug utilization studies = 7 9. Reserve anti-infective agents = 8 10. Drug information and educational activities = 10 11. Future developments = 11 12. Model List of Essential Drugs(eleventh list) = 13 13. Considerations and changes made in revising the model list = 46 14. Glossary of terms used in the report = 50 15. Alphabetical list of essential drugs = 53 References = 57